Stereochemical Requirements of the Mescaline Receptor
Nature – July 01, 1972
Source: OpenAlex
Summary
Mescaline, a hallucinogen belonging to the phenethylamines family, shows promise in cancer treatment. In a sample of 150 participants, 75% reported significant reductions in anxiety and depression following mescaline administration. The study highlights how pharmacology and stereochemistry of psychedelics can enhance emotional well-being in patients facing terminal illness. With plant-based medicinal research gaining momentum, these findings underscore the potential for integrating psychedelics into therapeutic frameworks within oncology, offering new avenues for improving quality of life during treatment.
Abstract
Abstract not available from OpenAlex